the beatles

Weekly Psychedelic Links - July 2022

7.1.22

Cannabis

  • Fentanyl-laced marijuana is a myth. It’s time to end the hype (Leafly)

  • Medical Weed Cards No Longer Required in Virginia Starting July 1 (High Times)

  • Hemp, CBD get permanent legal status in NC after 11th-hour rescue (MSN.com)

  • Scientists find THC in over 60% of CBD products they tested — and that may be a huge problem (ZME Science)

  • UN Report Dramatizes Uptick in Global Cannabis Use (High Times)

  • Louisiana Governor Signs Bill Providing Medical Marijuana Workplace Protections For State Employees (Marijuana Moment)

  • Maryland Court: Cops Can Stop, Question Someone Who Smells of Pot (High Times)

  • Nevada Cannabis Consumption Lounges Could Go Live By End Of 2022 (Marijuana Moment)

  • Edibles, beverages infused with cannabis ingredient THC become legal Friday in Minnesota (Star Tribune)

  • Inside The Process To Legalize Recreational Cannabis In Germany (Forbes)

  • California Bill to Require Cannabis Warnings About Mental Disorder Risks Advances (High Times)

  • Pennsylvania Lawmakers Advance Medical Marijuana DUI Protections And Cannabis Banking Reform Bills (Marijuana Moment)

  • Texas Supreme Court Bans Smokable Hemp Production, Sales (High Times)

  • Montana Lawsuit Challenges Marijuana Ban In State’s Third-Largest City (Marijuana Moment)

  • House Panel Approves Amendment to Protect State Legal Cannabis Programs (High Times)

  • Feds Fund Development Of Hemp-Based, 3D-Printed Materials To Build Affordable Housing (Marijuana Moment)

  • New Vermont Guidance Looks to Eliminate Plastic Waste From State’s Cannabis Industry (High Times)

  • Cannabis users are at greater risk for emergency and inpatient care: study (Fox News)

Magic Mushrooms

  • These Mormons Have Found a New Faith — in Magic Mushrooms (Rolling Stone)

  • New Jersey Senate President Files Psilocybin Legalization Bill That Includes Home Grow Option, Unlike Current Marijuana Law (Marijuana Moment)

  • Tryp Therapeutics Strengthens IP Portfolio with Provisional Patent Application for Binge Eating Disorder Treatment (Psychedelic Alpha)

  • Digging Up Druggable Targets: Psilocybin Efficacy in a Model of OCD (Psychedelic Science Review)

MDMA

  • First-of-its-kind MDMA group therapy trial set to commence (New Atlas)

  • Over One Hundred Years of MDMA Research (Drug Science)

Ayahuasca

  • How the Shipibo Came to Be the Most Common Group Serving Ayahuasca to Foreigners (DoubleBlind)

Peyote

  • Decriminalize Nature Targets Peyote: Drug Reform or Settler Colonialism? (Chacruna)

  • Big business could wipe out Mexico’s sacred psychedelic peyote cactus (openDemocracy)

Novel Psychoactive Substances

  • How Did A Minnesota Honor Roll Student Die As Her Parents Were Sleeping Upstairs? (Oxygen)

Synthetic Cannabinoids

  • A Loophole in Japan’s Weed Laws Is Getting Tens of Thousands High (VICE)

Miscellaneous

  • Colorado Activists Turn In Signatures To Put Psychedelics Legalization And Therapeutic Psilocybin Program On Ballot (Marijuana Moment)

  • War on drugs prolonged Colombia’s decades-long civil war, landmark report finds (The Guardian)

  • Is there a future for psychedelic treatment in Saudi Arabia? (Arab News)

  • Do Bad Psychedelic Patents Matter? (Lucid News)

  • 4 Recommendations for Disability Inclusion in Psychedelic Therapy Research (Psychiatric Times)

7.8.22

Cannabis

  • WNBA Star Brittney Griner Pleads Guilty To Cannabis Charge As Russia Calls Out U.S. Hypocrisy In Maintaining Criminalization (Marijuana Moment)

  • Make no mistake, marijuana edibles are legal now in Minnesota (Leafly)

  • Washington, D.C. Mayor Signs Medical Cannabis Self-Certification Bill (High Times)

  • Pennsylvania Bill Gives Medical Cannabis Patients DUI Protection (High Times)

  • Oklahoma: Advocates Turn in Signatures to Place Adult-Use Legalization Measure on November Ballot (NORML)

  • Study Shows Flower Still Reigns Supreme in U.S., Canada as Consumer Favorite (High Times)

  • Arkansas Activists Set To Turn In Double The Signatures Needed To Put Marijuana Legalization On Ballot (Marijuana Moment)

  • Nebraska Medical Marijuana Activists Turn In Ballot Signatures After Campaign Suffers Legal Setback (Marijuana Moment)

  • Albania Prompted to Implement Medical Cannabis Reform After U.N. Criticism (High Times)

  • U.S. Army Wants To Make Sniper Uniforms Out Of Hemp (Marijuana Moment)

LSD

  • A man whose daily headaches felt like an ice pick in his eyes says he tried 12 treatments but only found relief after taking LSD (Insider)

Magic Mushrooms

  • New Study Shows Mood, Mental Health Improved by Microdosing Psilocybin (High Times)

  • Indiana Nurse Faces Ten Years in Prison for Microdosing Psilocybin Mushrooms (Psychedelic Spotlight)

  • Two Cancer Patients Battle to Make Psilocybin Accessible for Palliative Care (Scientific American)

  • Rural Oregon counties are lining up against psilocybin launch (OPB)

MDMA

  • Alexandria Ocasio-Cortez Pushes for Psychedelic Reform in Congress (DoubleBlind)

  • GOP Congressman’s Amendment Would Direct Military To Study Psilocybin And MDMA Benefits For Service Members (Marijuana Moment)

DMT

  • Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study (Psychedelic Alpha)

Iboga

  • ‘To Heal and to Care for’: Protecting Iboga and Indigenous Voices in the Face of Corporatisation (Volteface)

Novel Psychoactive Substances

  • DEA Announces Hearing On Proposed Ban Of Five Psychedelic Compounds Following Significant Pushback (Marijuana Moment)

  • Mindset Pharma Receives Allowance for Patent Application Covering its Short-Duration Novel Psychedelic Medications for The Treatment of Central Nervous System Disorders (Psychedelic Alpha)

Ketamine

  • PharmaTher Announces Positive Results from Study For Ketamine Microneedle Patch (Psychedelic Alpha)

Miscellaneous

  • The Never-Ending Psychedelic Trip of Michael Pollan (Rolling Stone)

  • Journey Colab scores $12M to move psychedelics-based addiction treatment into clinic (Fierce Biotech)

  • User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study (Drug Science)

  • Tripping the Reward Circuit: Psychedelics for Substance Use Disorders (Psychedelic Science Review)

  • Psychedelics Give a Glimpse of Enlightenment (Psychology Today)

7.15.22

Cannabis

  • Feds Must Defend Historical Rationale Of Banning Guns For Medical Marijuana Patients, Revised Lawsuit Argues After SCOTUS Ruling (Marijuana Moment)

  • ‘Green way of life’: Thailand sees cannabis boom after law change (Al Jazeera)

  • Washington DC just legalized weed for all adults—but it’s locals only (Leafly)

  • Oklahoma, North Dakota, Arkansas, and Nebraska submit signatures to put cannabis on November ballot (Leafly)

  • Study Shows Decrease in Heavy Truck Crash Rates Since Cannabis Legalization (High Times)

  • NYPD Will Keep Testing Officers For Marijuana, Reversing Course Hours After Announcing Policy Change Mandated By City (Marijuana Moment)

  • Cannabis Laws in France Have Disproportionately Affected Muslims (High Times)

  • New York Firefighters Won’t Be Tested For Marijuana, Department Says Following NYPD Leak (Marijuana Moment)

  • Argentine Supreme Court Endorses Medical Cannabis Home Grow (High Times)

  • Pennsylvania Governor Signs Marijuana Banking And Insurance Reform Bill Into Law (Marijuana Moment)

  • Portland Weed Demand Hits Three-Year Low (High Times)

  • Pennsylvania Police Arrested Over 13,000 People for Marijuana Possession in 2021 (NORML)

  • The Fight for Medical Cannabis in Indonesia (High Times)

  • Weed, Like Change, Nourishes The Soil To Regenerate The Cannabis Industry (Forbes)

LSD

  • Why David Bowie wasn’t a fan of LSD (Far Out)

Magic Mushrooms

  • DEA May Find Itself In Federal Court Again Over Refusal To Provide Psilocybin Access To Terminally Ill Patients (Marijuana Moment)

  • Oregon therapeutic psilocybin program sparks some confusion (OPB)

MDMA

  • World's first ecstasy 'shop' set to trial in the Netherlands (Mixmag)

  • Luxury Champagne Recalled Again Over Ecstacy Contamination (Newsweek)

  • MDMA: Rolling from Counterculture to the Clinic Counter (Psychedelic Science Review)

Ayahuasca

  • Study suggests ayahuasca users tend to eat healthier, get more exercise, and experience physical and mental health benefits (PsyPost)

Ketamine

  • PharmaTher Announces Notice of Allowance for U.S. Patent Covering Ketamine for the Potential Treatment of Parkinson’s Disease and Motor Disorders (Psychedelic Alpha)

Miscellaneous

  • Ann Shulgin, Forerunner of Today's Psychedelic Re-Emergence, Dies at 91 (Transform Press)

  • House Approves Marijuana And Psychedelics Amendments As Part Of Must-Pass Defense Bill (Marijuana Moment)

  • What Ethnographers Have Learned from People Who Use Drugs (Undark)

  • Inside the Chemistry Lab Where the MDMA Godfather Synthesized Novel Psychedelics (DoubleBlind)

  • The Tory Leadership Candidates on Drugs (Volteface)

  • Filament Health Issued Third Patent By United States Patent and Trademark Office (Psychedelic Alpha)

  • Doctors Urge Access to Psychedelic Therapies in New Mexico (TIME)

  • Can Psychedelics Treat Inflammation and Eye Disease? Eleusis Thinks So. (Lucid News)

  • Villain Or Victim? Understanding The Role of Women In The Latin American Drug Trade (TalkingDrugs)

  • San Francisco’s New DA Vows to Ramp Up City’s Drug War (Filter)

  • The Battle for Psychedelic Patents (Psychedelic Spotlight)

  • How To Become a Psychedelic Therapist (DoubleBlind)

  • 5 Countries Where Psychedelics are Legal (Psychedelic Spotlight)

7.22.22

Cannabis

  • Senate Leadership Introduces Legislation to End Federal Marijuana Prohibition (NORML)

  • District of Columbia: Mayor Signs Legislation Prohibiting Most Employers from Discriminating Against Cannabis Consumers (NORML)

  • Legal cannabis is producing more plastic waste than pot (Leafly)

  • Colorado Company To Research Cannabis As A Treatment For Parkinson’s Disease (Forbes)

  • Biden Says He’s ‘Working On’ Bill To Release Cannabis Inmates (High Times)

  • Germany, Luxembourg, Malta And The Netherlands Discuss Marijuana Legalization At Historic Joint Meeting (Marijuana Moment)

  • Colorado Springs Recreational Cannabis Initiative Qualifies for November Ballot (High Times)

  • Minnesota Is Home To America's First Cannabis Disc Golf Course (MIX 108)

  • House Passes Bill Permitting Weed Ads on TV and Radio (High Times)

  • Colorado's New Lead Marijuana Monitor Treks Through Heavy Issues (Westword)

  • Cannabis Telemedicine Launches in Montana (High Times)

  • Montana Marijuana Businesses Face Seemingly Endless Cycle Of Local Votes On Allowing Them To Operate (Marijuana Moment)

  • People Busted for Weed in the U.K. Could Lose Passports Under Proposed Rules (High Times)

  • Missouri Marijuana Legalization Measure In Danger Of Not Qualifying For Ballot (Marijuana Moment)

  • Denver officials want to save struggling cannabis delivery businesses (The Denver Post)

  • Study Finds Australians Support Cannabis Use Over Smoking Tobacco (High Times)

  • House Will Not Vote On Marijuana Amendments For Veterans And Public Housing Residents After Committee Snag (Marijuana Moment)

  • Marijuana use is higher among US states that have legalized recreational cannabis use (News-Medical)

LSD

  • The Doors of Expression: LSD Alters Epigenetics and Protein Induction (Psychedelic Science Review)

  • Science Feature: MindMed’s LSD Trial for ADHD (Microdose)

  • Watch John Lennon explain that 'Lucy in the Sky with Diamonds' was not about LSD (Far Out)

Magic Mushrooms

  • The Sloppy Science of Psilocybin Microdosing Surveys (Psychedelic Spotlight)

  • A single dose of psilocybin has long-lasting antidepressant-like effects in fruit flies (PsyPost)

  • Restrictions on Psilocybin ‘Magic Mushrooms’ Are Easing as Research Ramps Up (Scientific American)

MDMA

  • Patient safety issues halt trial for MDMA-assisted psychotherapy during Health Canada review (CBC)

  • 'Corrective' measures ordered, but Health Canada says 2nd MDMA trial can continue (CBC)

DMT

  • Teenager Used LSD And DMT To Help Overcome Trauma, Case Report Says (IFLScience)

Ayahuasca

  • Churches sue to use hallucinogenic tea in religious practice (UPI)

  • The Global Ayahuasca Boom: What About the Conservation of the Ayahuasca Vine? (Chacruna)

5-MeO-DMT

  • The Story Behind a 1984 Hallucinogenic Pamphlet From Denton Is Just as Trippy as Its Subject (Dallas Observer)

Novel Psychoactive Substances

  • Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs (Psychedelic Alpha)

Synthetic Cannabinoids

  • Weed vapes probably sending a toxic gas to your lungs, study finds (Salon)

  • Cannabis getting stronger with synthetic versions added leading to psychosis, report warns (Independent.ie)

Ketamine

  • Largest-ever clinical study of ketamine therapy shows that at-home model can be a safe, effective treatment for anxiety and depression; 62% fewer patients report suicidal ideation after four sessions (PR Newswire)

  • Ketamine Beneficial For Treating Neonatal, And Pediatric Epilepsy: Study (Medical Dialogues)

Miscellaneous

  • The Long, Strange Relationship Between Psychedelics and Telepathy (VICE)

  • DEA Sued Over ‘Unlawful’ Delays On Psychedelic And Marijuana Public Records Requests Through FOIA (Marijuana Moment)

  • Colorado Psychedelics Legalization Measure Qualifies for November Ballot (DoubleBlind)

  • Keeping the Hippie Dream Alive (The New York Times)

  • Accessibility Is Key for the Psychedelic Revolution (Pharmacy Times)

  • Podcast aims to raise awareness about future of psychedelic treatments (CBC)

  • Skip the trip – does the world need non-hallucinogenic psychedelics? (leafie)

  • New Regulations for Psychedelics? Here's What Investors Need to Know (The Motley Fool)

7.29.22

Cannabis

  • Weedmaps again advertising illegal marijuana retailers and products, complaints allege (Marijuana Business Daily)

  • Singapore Executes Man for Cannabis Trafficking (High Times)

  • House Passes Bipartisan Marijuana Research Bill, With Senate Expected To Send It To President Soon (Marijuana Moment)

  • Zimbabwe OKs First Medicinal Cannabis Sales (High Times)

  • Secret Australian marijuana facility exposes location after turning sky pink (The Washington Post)

  • Biden Administration Proposes Prisoner Swap To Free Brittney Griner (High Times)

  • Over 850 Doctors in Thailand Protest Pot Legalization (High Times)

  • Senator Files Bill To Allow Marijuana Advertising On TV And Radio In Legal States (Marijuana Moment)

  • The 'World's Biggest Cannabis Scam' Is Totally Unravelling (VICE)

  • Bronx Cannabis Hub Fosters Opportunity in Communities Hit Hard by Arrests (Filter)

  • Cannabis Users Less Likely to Face Complications After Spinal Fusion Surgery (High Times)

  • 15 State Attorneys General File Brief Opposing Lawsuit To Help Put Medical Marijuana On Nebraska Ballot (Marijuana Moment)

  • Thai businesses cash in on cannabis, from milk tea to toothpaste (Reuters)

  • Missouri Marijuana Legalization Initiative Short Of Signatures Needed For Ballot In County Reviews (Marijuana Moment)

  • New Hampshire stands alone in New England as only state without legal marijuana (WMUR)

LSD

  • New Zealand Government Grants $650K For LSD Microdosing Trials (Benzinga)

  • Operation Julie: Rural Wales LSD bust becomes a musical (BBC)

Magic Mushrooms

  • DEA Sued Again Over Refusal To Allow Psilocybin Access For Patients Despite Federal Law (Marijuana Moment)

  • Why some of Colorado’s foremost shrooms advocates won’t be voting to legalize psilocybin (The Denver Post)

  • Legal psilocybin prescriptions in Canada (Drug Science)

  • Project Solace: The World’s Largest Medical Psilocybin Access and Data Project (Psychedelic Spotlight)

  • COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa (Psychedelic Alpha)

DMT

  • U.S. Patent Grant to Strengthen Small Pharma’s DMT Patent Strategy With Injectable Formulation (Psychedelic Alpha)

Novel Psychoactive Substances

  • DEA Cancels Proposed Ban Of Five Psychedelics, Giving Scientists More Time To Research Therapeutic Benefits (Marijuana Moment)

  • Working with Indigenous allies is the ethical way to develop psychedelic-based pharmaceuticals (STAT News)

  • Festival drugs: Warning over 'imposter' substances threat (BBC)

  • Ecstasy for the 21st Century: Designer Drugs to Improve MDMA Therapy (Psychedelic Science Review)

Synthetic Cannabinoids

  • Easy On The Eyes — This Company Reports Using a Unique Synthetic Cannabinoid Derivative To Treat Glaucoma (Benzinga)

Nitrous Oxide

  • Doctors warn ‘dangerous’ laughing gas is becoming an ‘epidemic’ amid rise in hospitalisations (The Independent)

  • A Law will Prohibit the Sale of Nitrous Oxide or “Laughing Gas” to Minors in Bulgaria (Novinite.com)

Ketamine

  • At Home Sublingual Ketamine Exhibits Rapid And Significant Antidepressant And Anxiolytic Effects (Medical Dialogues)

  • Ketamine found to be unlikely to lead to addiction (Medical Xpress)

  • Silo Pharma Announces Positive Results from its Topically Administered Formulation of Ketamine (Psychedelic Alpha)

Miscellaneous

  • Biden Administration Plans For Legal Psychedelic Therapies Within Two Years (The Intercept)

  • San Francisco Launches Bid to Decriminalize Psychedelics (Filter)

  • Your Genes May Determine How You React To Psychedelic Drugs (IFLScience)

  • The Psychoactive Substances Act on Trial (Volteface)

  • The High-Stakes Race to Engineer New Psychedelic Drugs (WIRED)

  • Trump Urges ‘Very Quick Trial’ and Death Penalty for Drug Dealers (High Times)

  • The Psychedelics Industry’s Next Hurdle Is How to Go Mainstream (Bloomberg)

  • One in four Americans say they’ve tried at least one psychedelic drug (YouGov)

  • Microdosing: Scientists tackle psychedelic trend becoming ‘creative enhancer of choice’ (The Sydney Morning Herald)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 12.3.21

Cannabis

  • Home of Dubai, the United Arab Emirates, Ends Jail Time for Travelers with THC (High Times)

  • Mexico has a new marijuana legalization bill. Here’s what’s in it (Leafly)

  • Reps. Dave Joyce and Alexandria Ocasio-Cortez Introduce Legislation To Expunge Marijuana Records (NORML)

  • South Dakota's Governor Succeeds in Blocking Voter-Approved Marijuana Legalization (Reason)

  • Fentanyl-laced vape pens among teens concern after Tennessee high school incident (WKYT)

  • Record Number of Scientific Papers Published About Cannabis in 2021 (NORML)

  • Death sentences upheld for two men convicted of cannabis trafficking (Singapore Law Watch)

  • California rolls out plans to standardize cannabis testing statewide (Marijuana Business Daily)

  • Jamaican Government Launches ‘Good Ganja Sense’ Campaign To Debunk Marijuana Myths (Marijuana Moment)

  • Great News, Scientists Finally Figured Out Why Cannabis Smells 'Skunky' (ScienceAlert)

  • Texas Activists Turn In Signatures To Put Marijuana Decriminalization On Austin’s 2022 Ballot (Marijuana Moment)

  • Kentucky Lawmaker Pre-Files Marijuana Legalization Bills For 2022 Session (Marijuana Moment)

  • Colorado University Announces Groundbreaking Study on Cannabis and Exercise (High Times)

  • Massachusetts: Majority of Adults Say Marijuana Legalization Has Been “Positive” for the State (NORML)

LSD

  • Blotter paper should be included while measuring weight of LSD, rules Bombay HC (India Today)

  • How LSD changed The Beatles forever (Far Out Magazine)

Magic Mushrooms

  • New Study Suggests SSRI Drugs Can Be Used Safely with Psilocybin to Treat Depression (Psychedelic Spotlight)

  • Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress (Psilocybin Alpha)

  • U of M Medical School launches new mechanistic study of psilocybin (University of Minnesota)

Ayahuasca

  • Sexual Assault in the Amazon (The Cut)

Iboga

Novel Psychoactive Substances

  • MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation (Psilocybin Alpha)

  • Bright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic Program for the Treatment of Mental Diseases (Psilocybin Alpha)

Nitrous Oxide

  • ‘Everyone’s gagging for it’ – how Britain got high on nitrous oxide (The Guardian)

  • Dozens of traffic accident deaths linked to laughing gas use (NL Times)

Ketamine

  • Ketamine review: Chemical restraints may have been ‘disproportionately’ used on ‘communities of color’ (KDVR)

  • As ketamine clinics emerge in Seattle to treat mental illness, so does debate about safety and regulations (The Seattle Times)

  • PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent Portfolio (Psilocybin Alpha)

Miscellaneous

  • New York City Opens First Safe Consumption Sites For Illegal Drugs In The U.S. (Marijuana Moment)

  • Florida Lawmaker Files Bill To Decriminalize All Currently Illicit Drugs (Marijuana Moment)

  • Toronto May Be the Next City to Decriminalize Psychedelics and Other Drugs (Truffle Report)

  • Study Shows People Who Use Psychedelics Were Under Less Stress During Covid-19 Lockdowns (Forbes)

  • DEA Again Boosts 2022 Production Goals For Psychedelics Like Psilocybin, MDMA and DMT (Marijuana Moment)

  • People ‘microdosing’ psychedelics to improve wellbeing during pandemic, drug survey finds (The Independent)

  • Psychedelics may have long-term impact treating depression, mental illness - study (The Jerusalem Post)

  • Psychedelic Telemedicine Has Arrived. What Could Possibly Go Wrong? (VICE)

  • The Psychedelic Renaissance Is Ushering In a New Genre Of Electronic Music — And With It, New Revenue Streams (Billboard)

  • Holiday Gift Guide 2021: Gifts For The Psychedelic Explorer (Forbes)

  • Can ethics and sexual abuse allegations create backlash and impact the current psychedelic renaissance? (Chacruna)

  • Will the psychedelic revolution bypass people of color? (The Lens)

  • Celebrities: Are They Helping or Harming the Psychedelic Movement? (Psychedelic Spotlight)

  • Origin Therapeutics Portfolio Company Tripsitter has Commenced Trading on the Canadian Securities Exchange (GlobeNewswire)

  • Peter Thiel-backed psychedelic start-up increases stake in Compass Pathways (CNBC)

  • Microdosing Protocols: Microdosing Every Day vs. Every Other Day (DoubleBlind)

  • Editor’s Choice Award 2021-Best Study on Psychedelics and Neurochemistry (Psychedelic Science Review)

  • Novel Psychedelic Treatment Approach Bypasses Hallucinogenic Effects to Allow Widespread Adoption (Pharmacy Times)

  • Israeli start up makes pharmaceuticals out of psychedelic flora (i24 News)

  • Getting Ahead of the Psychedelics Supply Crunch (Truffle Report)

  • Numinus Develops Proprietary Psychedelic Tests with New Toxicity and Potency Scans (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 2.12.21

ThisWeekinPsychedelics.png

Cannabis

  • Virginia lawmakers vote to legalize marijuana (8News)

  • Judge rules recreational marijuana measure unconstitutional in South Dakota (Sioux Falls Argus Leader)

  • Lax THC vape rules still allow toxins into your lungs (Leafly)

  • Idaho Medical Marijuana Activists Approved For Signature Gathering Amid Legislative Complications (Marijuana Moment)

  • Jamaica faces marijuana shortage as farmers struggle (AP News)

  • Wisconsin: Governor Evers Includes Marijuana Legalization in State Budget Proposal (NORML)

  • Connecticut Governor Includes Marijuana Legalization Plan In Budget Proposal (Marijuana Moment)

  • South Dakota governor to delay medical cannabis program until 2022 (Marijuana Business Daily)

  • The Half-Legal Cannabis Trap (Politico)

  • Bipartisan Marijuana Research Bill Reintroduced In The Senate (Marijuana Moment)

  • Poll: 61 Percent of US Adults Say Marijuana Legalization Is a “Good Idea” (NORML)

  • Medical cannabis law has been left in a haze (The Times)

  • New weed group tries to unify disparate cannabis factions (Politico)

  • TV Show Host and Travel Author Rick Steves to Chair NORML Board of Directors (NORML)

  • Mississippi Senate Approves Alternate Medical Marijuana Program, Hours After Defeating It (Marijuana Moment)

  • Weed Could Make Dogs Less Aggressive to Humans (VICE)

  • Starting A Business? Study Finds Marijuana May Help—And Hinder (Marijuana Moment)

  • Poll: Majority of North Carolina Voters Support Marijuana Legalization (NORML)

LSD

Magic Mushrooms

  • Texas Would Study Psilocybin And MDMA To Treat PTSD And Depression Under New Bill (Marijuana Moment)

  • Iowa GOP Lawmaker Makes Another Push To Decriminalize Psilocybin Mushrooms (Marijuana Moment)

  • New nonprofit aims to advise on creation of Oregon’s psilocybin-assisted therapy system (OPB)

  • Hackers, Mason Jars, and the Psychedelic Science of DIY Shrooms (WIRED)

  • Psyence Group Signs Collaboration Agreement with Leading Jamaican Psilocybin Retreat Provider to Conduct Observational Study (Psilocybin Alpha)

  • Nova Mentis Psilocybin Approved for Shipment to Italy (Psilocybin Alpha)

MDMA

DMT

5-MeO-DMT

  • Conservationists Plead With Public to Stop Milking Psychedelic Toads (Euronews)

Mescaline

Peyote

  • Blessings of Life and Peyote with Debi Roan (Chacruna)

Novel Psychoactive Substances

Ketamine

  • Regular oral doses of ketamine significantly reduce suicidal thoughts (New Atlas)

Miscellaneous

  • Can a Company Patent the Basic Components of Psychedelic Therapy? (VICE)

  • A Biotech Startup Won a Patent to Combine Elements of Weed and Psychedelics (Future Human)

  • Self-admitted psychedelic use and association with psychedelic culture harm perceptions of researchers’ scientific integrity (PsyPost)

  • New Professional Associations for Medical and Legal Practitioners Emerge for the Psychedelic Space (Lucid News)

  • This Weird, Futuristic Helmet Will Let People Scan Their Brains While Tripping (DoubleBlind)

  • 20-Year-Old Kansas Lawmaker Files Drug Decriminalization Bill (Marijuana Moment)

  • Black People Trip: Meet the Woman Creating Black Psychedelic Community (DoubleBlind)

  • MAPS, Fireside Project to Collaborate on Psychedelic Peer Support Line (Psych Congress Network)

  • Field Trip Health Ltd. Announces Official Opening of Psychedelic Research and Cultivation Facility in Jamaica (Psilocybin Alpha)

  • The case for mass producing psychedelic pharmaceuticals (Health Europa)

  • Psychedelic drug memo sparks uproar (The Australian)

  • Turn Off Your Mind, Relax—and Float Right-Wing? (Psymposia)

  • 3 Reasons You May Feel Unnecessary Guilt for Using Drugs (Medium)

  • Is Social Media the Best Place to Buy Drugs? (DoubleBlind)

  • Psychedelic Exploration (Maps of the Mind)

  • 10 Questions You Always Wanted to Ask a Psychedelic Lawyer (VICE)

  • Psychedelics And Spiritual Emergencies (Healing Maps)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.29.21

ThisWeekinPsychedelics.png

Cannabis

  • Arizona: Adult Use Marijuana Sales Begin (NORML)

  • 2 Years After Legalizing Cannabis, Has Canada Kept Its Promises? (The New York Times)

  • Alabama Could Legalize Medical Marijuana Under Bill Filed By Republican Senator (Marijuana Moment)

  • CBD Destroys Antibiotic-Resistant Bacteria Such as Gonorrhea, Study Finds (VICE)

  • Chuck Schumer Lists Marijuana As A Priority In First Post-Election Cannabis Comments (Marijuana Moment)

  • Anti-Marijuana Lawmaker Files Legalization Bill In North Dakota To Avoid Activist Ballot Measure (Marijuana Moment)

  • Areas With More Marijuana Dispensaries Have Fewer Opioid Deaths, New Study Finds (Marijuana Moment)

  • Opioid Prescriptions Decline in Canada Following Enactment of Adult-Use Marijuana Legalization (NORML)

  • Transition From Trump To Biden Impacts Federal Hemp And CBD Rules (Marijuana Moment)

  • Michigan testing labs sound warning about contaminated cannabis (Marijuana Business Daily)

  • Bill To Allow Medical Marijuana Use At Hotels And Airbnbs Filed In Missouri (Marijuana Moment)

LSD

  • LSD breakthrough could enable treatment for autism and social anxiety, research finds (Sky News)

Magic Mushrooms

  • Hawaii Could Legalize Psychedelic Mushroom Therapy Under New Senate Bill (Marijuana Moment)

  • Kevin Matthews Wants to Decriminalize Mushrooms Across Colorado (Westword)

  • Port Townsend woman seeks decriminalization of ‘magic’ mushrooms (Peninsula Daily News)

  • UK Regulators Approve Beckley Psytech Study of Psilocybin for Debilitating Headache Condition (Psilocybin Alpha)

  • Psyence Group Completes First Cultivation Cycle of Medical Psilocybin Mushrooms at Its Commercially Licensed Facility (Psilocybin Alpha)

  • Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland (Psilocybin Alpha)

  • MagicMed Files For Psilocybin Derived Patents (Green Market Report)

  • Is America Ready For Psilocybin Mushroom Retreats? (Benzinga)

MDMA

  • Will Australia legalise ecstasy and magic mushrooms to treat mental illness? Here’s why it’s still too soon (The Conversation)

DMT

Ayahuasca

  • Ayahuasca, Severe Illnesses, and the Mystery of Death (Chacruna)

  • Woman, 29, killed herself after ‘suffering psychosis from taking hallucinogenic yoga drugs on spiritual retreat’ (The Sun)

  • Ayahuasca’s Role in the Entourage Effect and Depression (Psychedelic Science Review)

  • An Ayahuasca Retreat Brings Powerful Changes (Healing Maps)

Peyote

  • Let’s Talk About Hikuri: A Peyote Conservation Project by the Wixárika (Chacruna)

Iboga

  • How the psychedelic Ibogaine helped a retired Vancouver firefighter treat his depression (The GrowthOp)

Novel Psychoactive Substances

  • BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies (Psilocybin Alpha)

Ketamine

  • Champignon Brands’ Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression (Psilocybin Alpha)

  • Ketamine to treat depression and addiction at UK’s first medical psychedelic psychotherapy clinic (iNews)

  • Users of ketamine at significantly higher risk of suicide: study (Focus Taiwan)

  • A Wall Street banker who made millions in the dot com boom dropped it all to become a 'psychedelics concierge' to the stars. Now he wants everyone to have access to ketamine. (Insider)

  • How to Know if Ketamine Therapy Is Right for You (Santa Clarita Magazine)

DXM

  • Low-dose dextromethorphan for the treatment of fibromyalgia pain: results from a longitudinal, single-blind, placebo-controlled pilot trial (MD Linx)

Miscellaneous

  • New Psychedelics Reform Group Sets Sights On Congress As Movement Builds (Marijuana Moment)

  • Atlanta: Mayor Takes Executive Action Abolishing Pre-Employment Drug Screens for Many Public Employees (NORML)

  • The Latest on Psychedelics for Treating Dementia (Psychedelic Science Review)

  • The world's first psychedelic ETF debuts (Yahoo! Finance)

  • Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US (Psilocybin Alpha)

  • The Cop Who Busted the Beatles Now Wants to Legalise All Drugs (VICE)

  • When The Giants Of Indian Classical Music Collided With Psychedelic San Francisco (NPR)

  • Mydecine Innovations Group Files Application to list to the NASDAQ (Psilocybin Alpha)

  • Biden Ending Federal Contracts With Private Prisons; Private ICE Detention Continues (Filter)

  • 5 Athletes Who Healed With Psychedelic Therapy (Benzinga)

  • “A ‘Dose’ of Radical Christianity”: Psychedelic Therapy with Dr. Florence Nichols (Chacruna)

  • atai Life Sciences to Collaborate with Massachusetts General Hospital to Accelerate Discovery of Mechanisms Underlying Therapeutic Effects of Psychedelic Agents (Psilocybin Alpha)

  • Ohio Students Launch Harm Reduction and “Bad Batch” Alerts App (Filter)

  • Taking Psychedelics When You’re Not Feeling Good (Maps of the Mind)

  • In Brazil, Bolsonaro Continues to Pump Blood to the War on Drugs (TalkingDrugs)

  • Inside The Underground World Of Online Psychedelic Support Groups (Benzinga)

  • MINDCURE Announces Pre- and Post-Psychedelic Therapy Adaptogen Supplements, Defining New Product Category (Psilocybin Alpha)

  • How to Start a Career in the Field of Psychedelic Integration (The Third Wave)

  • Field Trip Health Ltd. Common Shares to Trade on the OTCQX Best Market (Psilocybin Alpha)

  • Mental Health Issues That Don't Mix Well With Psychedelics (Healing Maps)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 6.26.20

ThisWeekinPsychedelics.png

Cannabis

  • New Jersey: Assembly Lawmakers Approve Marijuana Decriminalization Legislation (NORML)

  • Montana Activists Submit 130,000 Signatures For Marijuana Legalization Initiatives Despite Coronavirus Setbacks (Marijuana Moment)

  • Study: Cannabis Associated with Reduced Opioid Use, Prolonged Benefits in Pain Patients (NORML)

  • Police Would Have To Prove ‘Actual Impairment’ In Medical Marijuana DUIs Under New Pennsylvania Bill (Marijuana Moment)

  • Iowa Lost Over a Third of Its Medical Marijuana Patients During COVID-19 Crisis (MERRY JANE)

  • Marijuana Legalization Legend Dr. Lester Grinspoon Passes Away (CelebStoner)

  • Idaho Medical Marijuana Initiative Could Get New Chance At Ballot After Federal Court Ruling (Marijuana Moment)

  • MedMen’s Failure Is Everything Wrong With Legal Cannabis (And Is Only The First Company To Implode) (Forbes)

  • Gallup: Seven in Ten Americans Say That “Smoking Marijuana” Is Morally Acceptable (NORML)

  • Georgia Lawmakers Include Marijuana Decriminalization In Policing Reform Bill (Marijuana Moment)

  • Police boss says UK should regulate cannabis and allow home grows (Health Europa)

  • 7-Eleven Is Waging War on Medical Cannabis Businesses in Oklahoma (MERRY JANE)

  • New Jersey Announces Waiver Allowing Medical Marijuana Deliveries Ahead Of Legalization Referendum (Marijuana Moment)

  • In Wake of Protests, Cannabis Reforms Gain Momentum (WeedWeek)

  • Why 2021 Willl Be The Year For Marijuana Legalization (Benzinga)

  • Little-Noticed Hemp Memo Clarifies Military’s Ban On Service Members Using CBD (Marijuana Moment)

  • The Beneficial Effects of Cannabis on Post-Traumatic Stress Disorder Are Short Lived (Gilmore Health News)

LSD

Magic Mushrooms

  • Iowa GOP Lawmaker’s Psilocybin Decriminalization Amendment Defeated In Floor Vote (Marijuana Moment)

  • People are paying $10,000 to trip on magic mushrooms at a retreat in Jamaica. But past struggles with safety and staffing show the difficulty of taking psychedelics mainstream. (Insider)

  • Psilocybin Doses Used in Clinical Research & Conversions to Magic Truffle Dosages (Maps of the Mind)

  • Further Conversations With The Mushrooms On The Origin Of Everything (DMT Times)

MDMA

  • Psychiatrist Explores Possible Benefits Of Treating PTSD With Ecstasy Or Cannabis (NPR)

DMT

Ayahuasca

  • New trailer drops for documentary ‘The Medicine’ (HeyUGuys)

Iboga

  • The Multibillion-Dollar Opioid Crisis Has a Plant Medicine Solution (Stockhouse)

Ketamine

Miscellaneous

  • Survey: “Having Fun” Still the Biggest Reason for Drug Use During COVID Crisis (Filter)

  • GOP Memo Rips Into Joe Biden’s Drug War Record (Marijuana Moment)

  • What motivates people to use psychedelics: New criteria may help provide the answer (Medical Xpress)

  • Federal Commission Pushes Expansion Of Marijuana And Psychedelics Research For Military Veterans (Marijuana Moment)

  • Champignon Brands Issued Cease Trade Order By B.C. Securities Commission (The Dales Report)

  • 'The Happy Chef' To Release New Psychedelics Cookbook (Yahoo! Finance)

  • Guidelines for Inclusion of Indigenous People into Psychedelic Science Conferences (Chacruna)

  • How Culture Can Influence a Psychedelic Experience (Sam Woolfe)

  • New Bay Area Resilience Fund Provides Safety Net for Local Medicine Healers (Lucid News)

  • Washington State Drug Decriminalization Activists Shift Focus From Ballot To Legislature (Marijuana Moment)

  • Launch of the Medical Psychedelics Working Group (Drug Science)

  • Champignon Announces Regulatory Review (Globe Newswire)

  • Revive Therapeutics betting on psychedelics and potential COVID-19 treatment Bucillamine (Proactive Investors)

  • 'People Should Have the Fundamental Right To Change Their Consciousness' (Reason)

  • MindMed Developing IP For Personalized Psychedelic Assisted Therapies (PR Newswire)

  • Seattle repeals drug loitering law that led to racist harassment and arrests (Leafly)

  • Newton Energy Corporation Announces Letter of Intent with Field Trip Psychedelics Inc. (Globe Newswire)

  • How Psychedelics Help with Gender Identity and Transition (DoubleBlind)

  • Are NDEs caused by carbon dioxide overload? And what about psychedelics? (Patheos)

  • ATAI launches IntroSpect Digital Therapeutics, appoints veteran software engineer David Keene as CEO (PR Newswire)

  • iCan Founder Saul Kaye Joins Aurelius Data Advisory Board (Globe Newswire)

  • Field Trip Psychedelics Announces New Podcast, Field Tripping: Epic Trips in Psychedelics (PR Newswire)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.